-+ 0.00%
-+ 0.00%
-+ 0.00%

SPYRE THERAPEUTICS ANNOUNCES LAUNCH OF SPY772 PROGRAM AND INITIATION OF PHASE 2 SKYLIGHT TRIAL IN HIDRADENITIS SUPPURATIVA

路透·08/10/2026 12:00:00

登錄查看新聞詳情